recurrence (FCR) among human papillomavirus (HPV)-associated oropharyngeal cancer
(OPC) survivors. Methods and Materials We conducted a cross-sectional study in HPV-OPC
survivors≥ 12 months from completion of definitive (chemo) radiation therapy (RT/CRT).
Eligible patients completed the Fear of Cancer Recurrence Inventory short-form (FCRI-SF),
the European Organisation for research and Treatment of Cancer QLQ-C30, MD Anderson …